- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by CSL Behring
Total 4331 results
-
CSL BehringCompleted
-
CSL BehringCompleted
-
CSL BehringCompletedHereditary AngioedemaUnited States, Germany, Japan, Hungary, Canada, Netherlands, Israel
-
CSL BehringCompletedHereditary AngioedemaCanada, Australia, Germany, United States, Israel
-
CSL BehringCompleted
-
CSL BehringTerminatedAntibody-mediated RejectionUnited States, Spain, France, Netherlands, United Kingdom, Belgium, Germany
-
CSL BehringCompletedHemophilia BUnited States, Australia, Japan, France, Philippines, Spain, Czechia, Israel, Canada, Germany, Austria, Bulgaria, Italy, Malaysia, South Africa
-
CSL BehringTerminatedCrohn's DiseaseGermany, India, Korea, Republic of, Taiwan, United States, Hong Kong, Canada, Mexico, Austria, Switzerland, Israel, Italy, France, Poland, Netherlands, Hungary, Czechia, United Kingdom
-
CSL BehringCompletedAcute Myocardial InfarctionUnited States, Australia, Austria, Bulgaria, Canada, Czechia, Denmark, France, Germany, Hungary, Israel, Italy, Netherlands, Poland, Spain, United Kingdom
-
CSL BehringTerminatedChronic Inflammatory Demyelinating PolyneuropathyFrance
-
CSL BehringCompletedAcute Myocardial Infarction | Moderate Renal ImpairmentUnited States, Germany, Hungary, Israel, Netherlands
-
CSL BehringCompletedPolyradiculoneuropathy, Chronic Inflammatory Demyelinating | Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)United States, Japan, Australia, Canada, Czechia, France, Germany, Italy, Netherlands, Spain, United Kingdom
-
CSL BehringCompletedPrimary Immune Deficiency | Secondary Immune DeficiencyCanada
-
CSL BehringCompletedAcute Myocardial InfarctionGermany, United Kingdom
-
CSL BehringCompletedHereditary Angioedema Types I and IIBulgaria, Hungary, Poland, Romania
-
CSL BehringCompletedEmphysema | Alpha 1-proteinase Inhibitor DeficiencyAustralia, Canada, Czech Republic, Denmark, Estonia, Finland, Germany, Ireland, Poland, Romania, Sweden
-
CSL BehringCompletedHemophilia BBulgaria, Israel
-
CSL BehringCompletedEmphysema | Alpha1-proteinase Inhibitor DeficiencyAustralia, Russian Federation, United States, Denmark, Estonia, Finland, Germany, Ireland, Poland, Romania, Sweden, Canada, Czech Republic
-
CSL BehringCompleted
-
CSL BehringCompletedPrimary Immunodeficiency (PID)Poland, Germany, France, Romania, Spain, Sweden, Switzerland, United Kingdom
-
CSL BehringCompleted
-
CSL BehringCompletedMultifocal Motor Neuropathy (MMN)Switzerland, Italy, United Kingdom
-
CSL BehringCompletedHereditary Angioedema Types I and IIGermany
-
CSL BehringCompletedFactor XIII DeficiencyUnited States, Spain
-
CSL BehringCompletedCystic FibrosisBulgaria, Hungary, Poland, United Kingdom
-
CSL BehringCompletedVon Willebrand DiseaseCanada
-
CSL BehringCompletedPrimary Immune DeficiencyUnited States
-
CSL BehringRecruitingHereditary Angioedema (HAE)United States, Germany, Israel, Australia, Canada
-
CSL BehringRecruitingChronic Inflammatory Demyelinating PolyneuropathyFrance
-
CSL BehringActive, not recruitingHemophilia BUnited States, Belgium, Netherlands, Denmark, Germany, Ireland, Sweden, United Kingdom
-
CSL BehringActive, not recruitingDermatomyositisUnited States, Argentina, Belgium, France, Germany, Hungary, Italy, Japan, Mexico, Poland, Russian Federation, Spain, Switzerland, Ukraine
-
CSL BehringActive, not recruitingAlpha-1 Antitrypsin DeficiencyFrance
-
CSL BehringCompletedNoncystic Fibrosis Bronchiectasis (NCFB)United Kingdom, Germany
-
CSL BehringCompletedDiabetic Kidney Disease (DKD)United States, Australia, New Zealand, Puerto Rico, Canada, Israel
-
CSL BehringTerminatedImmune Complex-mediated Autoimmune DiseasesUnited Kingdom
-
CSL BehringWithdrawnAfibrinogenemia | Hypofibrinogenemia | Fibrinogen Deficiency
-
CSL BehringCompletedA Study to Assess the Pharmacokinetics and Safety of CSL312 in Healthy Japanese and Caucasian AdultsHealthy VolunteersUnited States
-
CSL BehringCompletedHemophilia BGermany, Denmark, Netherlands
-
CSL BehringCompletedCoronavirus Disease 2019 (COVID-19)United States
-
CSL BehringCompletedRheumatoid ArthritisItaly, Japan, Taiwan, United States, Spain, Argentina, Belgium, Germany, Korea, Republic of, Czechia, Russian Federation, France, Mexico, Poland, South Africa, Hungary, Brazil, Canada, Netherlands
-
CSL BehringCompletedArthritis, PsoriaticItaly, United States, Canada, Mexico, Poland, Spain, Germany, Czechia, Russian Federation, Australia, South Africa, Argentina, Hungary
-
CSL BehringCompletedHemophilia A | Severe Hemophilia AUnited States, Australia, Austria, Canada, Czechia, France, Georgia, Germany, Hungary, Ireland, Italy, Japan, Lebanon, Malaysia, Netherlands, Philippines, Poland, Portugal, Romania, South Africa, Spain, Switzerland, Thailand, Ukraine, United...
-
CSL BehringTerminatedHealthyUnited Kingdom, Netherlands
-
CSL BehringCompletedPrimary ImmunodeficiencyUnited States, Canada
-
CSL BehringWithdrawn
-
CSL BehringTerminatedHemophilia A With Inhibitors | Hemophilia B With InhibitorsGeorgia, Italy, Malaysia, Russian Federation, South Africa, Spain, Thailand, Ukraine, United Kingdom
-
CSL BehringCompletedHereditary Angioedema Types I and IIUnited States, Spain, Germany, Australia, Canada, Czechia, Hungary, Israel, Italy, Romania, United Kingdom
-
CSL BehringCompletedVon Willebrand DiseasePoland, Germany, Austria, Greece, United Kingdom
-
CSL BehringTerminatedHemophilia ARussian Federation, Germany, Italy, Austria, Greece